Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to ...
Maze Therapeutics begins Phase 2 trial for kidney disease drug
Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company with a market capitalization of $569 million, has dosed the first patient in its Phase 2 HORIZON Study of MZE829, ...
TikTok Has A Simple Exit From U.S. Ban Maze
With Trump back in charge, a long list of mooted, familiar buyers is re-emerging. The simplest way to scroll past this glitch ...
FierceBiotech11d
Maze rolls out map to $131M IPO, as phase 2 kidney disease trial readies for dosing
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...
Maze Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know
Maze Therapeutics, Inc MAZE IPO will take place January, 31 on the NASDAQ exchange under the ticker MAZE. The company is offering shares at an expected price between $15.00 and $17.00 per share with ...
University of California1d
Researchers solve a fluid mechanics mystery
UC Santa Barbara researchers now know why a pool of red dye somehow “knew” how to solve a maze filled with milk.
FierceBiotech7d
Busy day for biotech IPOs as Metsera, Maze go public with offerings totaling nearly $400M
Obesity biotech Metsera and renal and metabolic-focused Maze Therapeutics have met their IPO expectations as the two companies prepare to join the Nasdaq this morning. | Obesity biotech Metsera and ...
MinnPost9d
Is Minnesota home to the largest ice maze in the world?
Until this year, the Guinness World Record was held by a nearly 13,000-square-foot ice labyrinth in New York that took the ...